The Mark Foundation is committed to supporting the most exciting projects in cancer research throughout their life cycle, ensuring their highest chance of success in impacting the lives of patients with breakthroughs in cancer care. We provide venture capital funding to companies with rigorous research programs that have transformative potential across multiple cancer indications. We initially invest at the Seed, Series A, and Series B stages and continue to support our portfolio companies with follow-on investment as well as strategic and operational resources. Our dual strategy includes continuing to fund the most promising projects from within our research portfolio as they make the transition to commercial development, and looking externally for high-risk/high-reward opportunities with a tangible path toward dramatically improving cancer prevention, diagnosis, or therapy. All returns realized from our portfolio are put back into The Mark Foundation to enable additional support for cutting edge cancer research in the form of new grants or investments. If you are interested in learning more about venture investing at The Mark Foundation, please send an email to email@example.com.